alias::
ICD-11_Code::
tags:: disease, medicine, cardiology
high-yeild:: true

- ## Etiology
  background-color:: blue
	- ### Causative Agents
	- ### Risk Factors
		- Hypothyroidism
- ## Epidemiology
  background-color:: blue
	- ### Incidence
	- ### Prevalence
		- ### Demographics
	- ### Geographic Distribution
- ## Pathophysiology
  background-color:: blue
	- ### Mechanism of Disease
	- ### Affected Systems/Organs
- ## Clinical Features
  background-color:: blue
	- ### Clinical Presentation
		- #### Symptoms
		- #### Signs
	- ### Stages or Classification
		- Ventricular Tachycardia
		- Ventricular Fibrillation
		- Pulseless Electrical Activity
		- Asystole
- ## Diagnosis
  background-color:: blue
	- ### Diagnostic Criteria
	- ### Investigation
		- ### Establishing Diagnosis
		- ### Ruling Out Differential Diagnosis
			- | **Differential Diagnosis** | **Shared Features** | **Clinical Exclusion** | **Baseline Workup** (Perform even if no suspicion) | **Direct Testing** (Perform if suspicion) |
			  |--|--|--|--|--|
			  |-|-|-|-|-|
		- ### General Assessment
- ## Management and Treatment
  background-color:: blue
	- ### Medical Treatment
		- Peroxysmal -> spontaneous resolution in 7 days
			- if not, beta blocker
		- Persistent
			- Rate -> beta blocker, ..
			- Rythm
				- Electric Cardiacversion
					- DC Shock
				- Chemical Cardiacversion
					- Flecanide
					- Amiadarone
		- Permanent
			- Pacemaker
			- Pace and Ablation therapy
		- Prevention of Complication
			- Oral anticoagulant -> Warfarin
			- based on CHaDSVASc score
	- ### Surgical Options
	- ### Lifestyle and Dietary Recommendations
	- ### Follow-up
- ## Prognosis
  background-color:: blue
	- ### Expected Course
		- #### With Treatment
		- #### Without Treatment
			- ##### Possible Complications
				- Thromboembolism
				- Stroke
			- ##### Long-Term Effects
	- ### Survival Rates
		- #### With Treatment
		- #### Without Treatment
	- ### Quality of Life Considerations
- ## Prevention
  background-color:: blue
	- ### Health Education
	- ### Community Approach
	- ### Screening Programs
	- ### Lifestyle Modifications
- ## Patient Education and Support
  background-color:: blue
	- ### Educational Resources
	- ### Support Groups
	- ### Counseling Options
- ## Recent Research and Developments
  background-color:: blue
	- ### Ongoing Clinical Trials
	- ### Recent Advances
- ## Key Literature
  background-color:: blue
- ## Guidelines and Protocols
  background-color:: blue